Pharmacotherapy of head and neck cancer.

about

Treatment of head and neck cancer in the elderly.

P2860

Q38958367-6323F26A-4EDD-4A55-A8BB-390E00B09ADB

P2860

Pharmacotherapy of head and neck cancer.

Item

http://www.wikidata.org/entity/Q38619293

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacotherapy of head and neck cancer.

@en

type

Item

label

Pharmacotherapy of head and neck cancer.

@en

prefLabel

Pharmacotherapy of head and neck cancer.

@en

P1476

Pharmacotherapy of head and neck cancer.

@en

P2093

David Adelstein

http://www.w3.org/2001/XMLSchema#string

Tobenna Nwizu

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Cancer statistics, 2014

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

ERBB receptors and cancer: the complexity of targeted inhibitors

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

P304

2409-2422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1085507

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26513647

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Pharmacotherapy of head and neck cancer.

about

P2860

P2860

Pharmacotherapy of head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921